(Q37368987)

20 August 2017

1 reference

title

Cardiac and systemic haemodynamic complications of liver cirrhosis (English)

1 reference

20 August 2017

0 references

1 reference

Jens H Henriksen

1

1 reference

20 August 2017

Søren Møller

series ordinal

2

1 reference

20 August 2017

publication date

1 August 2009

1 reference

Scandinavian Cardiovascular Journal

20 August 2017

published in

1 reference

20 August 2017

volume

43

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

218-225

1 reference

Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Hemodynamic alterations in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

The cardiac output at rest in Laennec's cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Pathogenetic background for treatment of ascites and hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cardiovascular complications of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

The role of central blood volume in the development of sodium retention in portal hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Water and sodium retention in edematous disorders: role of vasopressin and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cirrhotic cardiomyopathy: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cirrhotic cardiomyopathy: an endocannabinoid connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cardiac and vascular changes in cirrhosis: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Cardiac electrophysiological abnormalities in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802691528

10.1080/14017430802691528

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference